WeVote
Log In

Bill

Bill

HB 1160

repeal the medical marijuana oversight committee.

2026 Regular Session Introduced by Tim Goodwin and 2 co-sponsors

South Dakota bill repeals medical marijuana oversight committee, eliminating dedicated regulatory supervision of the state's cannabis program's safety and operations.

Health and Human Services Report out of committee without recommendation , Passed,
#legislativeoversight #medicalcannabis #publichealthandsafety #reports
0
WeVote Research Nonpartisan
Bill Summary · HB 1160

Legislative bill overview

HB 1160 proposes to eliminate South Dakota's medical marijuana oversight committee, which currently monitors and regulates the state's medical cannabis program. The bill passed a House Health and Human Services committee vote (8-5) and is scheduled for further consideration.

Why is this important

Medical marijuana programs require regulatory oversight to ensure product safety, prevent diversion to illegal markets, and protect patient access. Removing this committee would eliminate dedicated supervision of South Dakota's medical cannabis operations, potentially creating gaps in quality control, licensing enforcement, and patient protections.

Potential points of contention

  • Regulatory vacuum: Eliminating oversight without clearly reassigning responsibilities could leave the medical marijuana program without adequate monitoring and enforcement mechanisms
  • Program integrity concerns: Without a dedicated committee, there may be reduced ability to prevent product contamination, unlicensed dispensaries, or diversion to recreational markets
  • Patient access questions: Unclear how medical marijuana patients would be protected or how their access would be managed without a formal oversight body
  • Cost versus accountability trade-off: While elimination might reduce costs, it sacrifices institutional accountability and expert review of program operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.